Sanz-Solas, A.; Labrador, J.; Alcaraz, R.; Cuevas, B.; Vinuesa, R.; Cuevas, M.V.; Saiz-Rodríguez, M.
Bortezomib Pharmacogenetic Biomarkers for the Treatment of Multiple Myeloma: Review and Future Perspectives. J. Pers. Med. 2023, 13, 695.
https://doi.org/10.3390/jpm13040695
AMA Style
Sanz-Solas A, Labrador J, Alcaraz R, Cuevas B, Vinuesa R, Cuevas MV, Saiz-Rodríguez M.
Bortezomib Pharmacogenetic Biomarkers for the Treatment of Multiple Myeloma: Review and Future Perspectives. Journal of Personalized Medicine. 2023; 13(4):695.
https://doi.org/10.3390/jpm13040695
Chicago/Turabian Style
Sanz-Solas, Antonio, Jorge Labrador, Raquel Alcaraz, Beatriz Cuevas, Raquel Vinuesa, María Victoria Cuevas, and Miriam Saiz-Rodríguez.
2023. "Bortezomib Pharmacogenetic Biomarkers for the Treatment of Multiple Myeloma: Review and Future Perspectives" Journal of Personalized Medicine 13, no. 4: 695.
https://doi.org/10.3390/jpm13040695
APA Style
Sanz-Solas, A., Labrador, J., Alcaraz, R., Cuevas, B., Vinuesa, R., Cuevas, M. V., & Saiz-Rodríguez, M.
(2023). Bortezomib Pharmacogenetic Biomarkers for the Treatment of Multiple Myeloma: Review and Future Perspectives. Journal of Personalized Medicine, 13(4), 695.
https://doi.org/10.3390/jpm13040695
